Literature DB >> 19112073

Integration of alcohol use disorders identification and management in the tuberculosis programme in Tomsk Oblast, Russia.

Trini A Mathew1, Sergey A Yanov, Rais Mazitov, Sergey P Mishustin, Aivar K Strelis, Galina V Yanova, Vera T Golubchikova, Dmitry V Taran, Alex Golubkov, Alan L Shields, Shelly F Greenfield, Sonya S Shin.   

Abstract

Alcohol use disorders (AUDs) among tuberculosis (TB) patients are associated with nonadherence and poor treatment outcomes. We developed a multidisciplinary model to manage AUDs among TB patients in Tomsk, Russia. First, we assessed current standards of care through stakeholder meetings and ethnographic work. The Alcohol Use Disorders Identification Test (AUDIT) was incorporated into routine assessment of all patients starting TB treatment. We established treatment algorithms based on AUDIT scores. We then hired specialists and addressed licensing requirements to provide on-site addictions care. Our experience offers a successful model in the management of co-occurring AUDs among patients with chronic medical problems.

Entities:  

Mesh:

Year:  2008        PMID: 19112073      PMCID: PMC2720714          DOI: 10.1093/eurpub/ckn093

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  4 in total

1.  Causes of death during tuberculosis treatment in Tomsk Oblast, Russia.

Authors:  T A Mathew; T N Ovsyanikova; S S Shin; I Gelmanova; D A Balbuena; S Atwood; G G Peremitin; A K Strelis; M B Murray
Journal:  Int J Tuberc Lung Dis       Date:  2006-08       Impact factor: 2.373

2.  Risk factors for pulmonary tuberculosis in Russia: case-control study.

Authors:  Richard Coker; Martin McKee; Rifat Atun; Boika Dimitrova; Ekaterina Dodonova; Sergei Kuznetsov; Francis Drobniewski
Journal:  BMJ       Date:  2005-12-08

3.  Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients.

Authors:  M F Fleming; E Krupitsky; M Tsoy; E Zvartau; N Brazhenko; W Jakubowiak; M E McCaul
Journal:  Int J Tuberc Lung Dis       Date:  2006-05       Impact factor: 2.373

4.  Risk factors for death during tuberculosis treatment in Orel, Russia.

Authors:  P K Dewan; P M Arguin; H Kiryanova; N V Kondroshova; T M Khorosheva; K Laserson; H Kluge; W Jakubowiak; C Wells; B Kazionny
Journal:  Int J Tuberc Lung Dis       Date:  2004-05       Impact factor: 2.373

  4 in total
  22 in total

1.  One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.

Authors: 
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

2.  Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation.

Authors:  A C Miller; I Y Gelmanova; S Keshavjee; S Atwood; G Yanova; S Mishustin; J J Furin; S S Shin
Journal:  Int J Tuberc Lung Dis       Date:  2012-04-09       Impact factor: 2.373

3.  Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia.

Authors:  Sonya Shin; Viktoria Livchits; Hilary Smith Connery; Alan Shields; Sergei Yanov; Galina Yanova; Garrett M Fitzmaurice; Adrianne K Nelson; Shelly F Greenfield
Journal:  Addiction       Date:  2013-05-13       Impact factor: 6.526

4.  Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation.

Authors:  Shelly F Greenfield; Alan Shields; Hilary Smith Connery; Viktoriya Livchits; Sergey A Yanov; Charmaine S Lastimoso; Aivar K Strelis; Sergey P Mishustin; Garrett Fitzmaurice; Trini A Mathew; Sonya Shin
Journal:  Alcohol Clin Exp Res       Date:  2009-11-20       Impact factor: 3.455

5.  Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana.

Authors:  N M Zetola; C Modongo; E C Kip; R Gross; G P Bisson; R G Collman
Journal:  Int J Tuberc Lung Dis       Date:  2012-09-07       Impact factor: 2.373

6.  Substance Use Disorders in Global Mental Health Delivery: Epidemiology, Treatment Gap, and Implementation of Evidence-Based Treatments.

Authors:  Hilary S Connery; R Kathryn McHugh; Meghan Reilly; Sonya Shin; Shelly F Greenfield
Journal:  Harv Rev Psychiatry       Date:  2020 Sep/Oct       Impact factor: 3.732

7.  Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors.

Authors:  Alena Skrahina; Henadz Hurevich; Aksana Zalutskaya; Evgeni Sahalchyk; Andrei Astrauko; Sven Hoffner; Valiantsin Rusovich; Andrei Dadu; Pierpaolo de Colombani; Masoud Dara; Wayne van Gemert; Matteo Zignol
Journal:  Bull World Health Organ       Date:  2012-11-26       Impact factor: 9.408

8.  Prevalence of Tuberculosis Risk Factors among Bacteriologically Negative and Bacteriologically Confirmed Tuberculosis Patients from Five Regional Referral Hospitals in Uganda.

Authors:  Winters Muttamba; Bruce Kirenga; Willy Ssengooba; Rogers Sekibira; Achilles Katamba; Moses L Joloba
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

Review 9.  Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis.

Authors:  James C Johnston; Neal C Shahidi; Mohsen Sadatsafavi; J Mark Fitzgerald
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

10.  Alcohol use disorders in multidrug resistant tuberculosis (MDR-TB) patients and their non-tuberculosis family contacts in Nigeria.

Authors:  Victor Olufolahan Lasebikan; Olusoji Mayowa Ige
Journal:  Pan Afr Med J       Date:  2020-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.